Effect of ATRX and G-Quadruplex Formation by the VNTR Sequence on α-Globin Gene Expression by Li, Yue et al.
Title Effect of ATRX and G-Quadruplex Formation by the VNTRSequence on α-Globin Gene Expression
Author(s)Li, Yue; Syed, Junetha; Suzuki, Yuki; Asamitsu, Sefan;Shioda, Norifumi; Wada, Takahito; Sugiyama, Hiroshi




This is the accepted version of the following article: [Yue Li,
Junetha Syed, Yuki Suzuki, Sefan Asamitsu, Norifumi Shioda,
Takahito Wada, Hiroshi Sugiyama. Effect of ATRX and G‐
Quadruplex Formation by the VNTR Sequence on α‐Globin
Gene Expression. ChemBioChem (2016), 17, 10, 928-935],
which has been published in final form at
https://doi.org/10.1002/cbic.201500655. This article may be
used for non-commercial purposes in accordance with Wiley
Terms and Conditions for Self-Archiving.; The full-text file
will be made open to the public on 17 May 2017 in accordance
with publisher's 'Terms and Conditions for Self-Archiving'.;






FULL PAPER    





Effect of ATRX and G-quadruplex formation by the VNTR 
sequence on α-globin gene expression 
Yue Li,[a] Junetha Syed,[a] Yuki Suzuki,[a] Sefan Asamitsu,[a] Norifumi Shioda,[c] Takahito Wada,[d] and 
Hiroshi Sugiyama,*[a, b]  
Abstract: ATR-X (α-thalassemia/mental retardation syndrome X-
linked) syndrome is caused by mutations in chromatin-remodeler 
ATRX. ATRX can bind the variable number of tandem repeats 
(VNTR) sequence in the promoter region of the α-globin gene 
cluster. The VNTR sequence, which contains the potential G-
quadruplex-forming sequence CGC(GGGGCGGGG)n, is involved in 
the downregulation of α-globin expression. We investigated the G-
quadruplex and i-motif formation in the single-stranded DNA and 
long double-stranded DNA. The promoter region without the VNTR 
sequence showed approximately two fold higher luciferase activity 
than the promoter region harboring VNTR sequence. G-quadruplex 
stabilizers hemin and TMPyP4 reduced the luciferase activity 
whereas expression of ATRX led to a recovery in reporter activity. 
Our results demonstrate that stable G-quadruplex formation by the 
VNTR sequence downregulates the expression of α-globin genes 
and that ATRX might bind to and resolve the G-quadruplex.  
Introduction 
ATRX is a SWI/SNF-like chromatin remodeler that can bind to 
the histone chaperone DAXX and incorporate the variant histone 
H3.3 into telomeric and pericentromeric heterochromatin.[1-5] It 
comprises several conserved protein-binding domains that are 
critical to its functions, such as the ATRX-DNMT3-DNMT3L 
(ADD) domain and the helicase domain.[6, 7] The ADD domain 
was found to bind histone H3 by recognizing lysine 9 
trimethylation (H3K9me3)[8, 9] and the ATP-dependent triplex 
displacement activity of ATRX-DAXX complex suggested the 
potential function of helicase domain in the presence of ATP.[1] 
Numerous mutations located within the ATRX protein coding 
sequence give rise to ATR-X syndrome, which is characterized 
by developmental disabilities, α-thalassemia, and cognitive 
deficits.[10-14] Studies on α-thalassemia suggested that ATRX 
could affect α-globin expression by controlling the incorporation 
of repressive macroH2A1 histone variant to the chromatin.[15] 
Mouse models of the ATR-X mental retardation syndrome are 
characterized by the activation of imprinted genes and abnormal 
dendritic spine formation[16-18] due to the loss of functional ATRX 
in the neonatal brain. However, the underlying mechanism of 
how these ATRX mutations induce the symptoms of ATR-X 
syndrome is not clear and effective treatments for ATR-X 
syndrome are yet to be developed.  Recent studies also 
demonstrated the role of functional ATRX as tumor suppressor 
protein that negatively regulates the process of alternative 
lengthening of telomeres (ALT) in cancer cells.[19-20]  
 
Many human disorders are caused by expandable DNA repeats, 
which are thought to form unusual structures that can disrupt 
cellular replication, repair, and recombination machineries.[21] 
Such repeats can be located in either coding or noncoding 
regions of important genes. Many of these repeats are GC-rich 
sequences with the potential to form G-quadruplex structures, 
which are stabilized by Hoogsteen hydrogen bonds and central 
cations such as K+ or Na+.[22-24] For example, in the coding 
region of C9orf72, a hexanucleotide repeat expansion 
(GGGGCC)n forms DNA G-quadruplexes that stalls the 
transcription machinery and produces G-quadruplexes 
containing truncated RNA transcripts which in turn is responsible 
to the pathogenesis associated with amyotrophic lateral 
sclerosis and frontotemporal dementia (ALS/FTD).[25, 26] Similar 
studies in the promoter region of human insulin gene 
demonstrated the formation of multiple G-quadruplexes by the 
insulin-linked polymorphic region (ILPR) that may regulate 
insulin expression in insulin-dependent diabetes mellitus.[27, 28] 
These results suggested that G-quadruplexes formed by GC-
rich repeats might provide the basis for a mechanistic model for 
repeat-associated diseases. Regarding the G-quadruplexes, 
various forms have been identified including DNA, RNA, and 
DNA/RNA hybrid G-quadruplexes and the formations of G-
quadruplexes have been well studied by different methods in 
vitro and in vivo.[29-32] Proteins with binding affinity towards these 
G-quadruplexes have also been identified, suggesting the 
importance of G-quadruplex structures in cellular processes.[33-35] 
Furthermore, several small molecules have been developed to 
target G-quadruplex formation to treat a number of diseases.[36-
38]  
 
Recently, ChIP-sequencing and gel shift studies revealed that 
ATRX could bind to G-quadruplex structures formed by GC-rich 
sequences in human genomic DNA.[39] It was proposed that 
ATRX could enable the passage of transcriptional machinery 
through GC-rich coding regions by binding to and resolving G-
quadruplex structures along with the incorporation of the variant 
H3.3 within the transcribed genes.[39, 40]  In human α-globin gene 
clusters, a variable number of tandem repeats (VNTR) 
CGC(GGGGCGGGG)n lies 1 kb upstream of the HBM promoter. 
The size of the VNTR is variable among individuals and it is 
closely related to the downregulation of α-globin gene 
expression.[39] It seems that ATRX binds to and resolves G-
quadruplex formation by the VNTR and facilitates α-globin 
expression. However, questions concerning the G-quadruplexes 
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formation in VNTR sequence, the role of ATRX and how 
mutations in ATRX protein induce α-thalassemia remain to be 
resolved. 
 
In this study, we investigated the formation of G-quadruplex by 
the VNTR sequence using CD, UV and gel analysis. The ability 
of G-quadruplex formation by the VNTR sequence in long 
double-stranded DNA was also analysed and observed by 
Atomic Force Microscopy (AFM). Well-characterized G-
quadruplex binding ligands such as hemin and TMPyP4 were 
studied for their binding affinity to the proposed G-quadruplexes 
formed by VNTR sequences. The gene regulatory effect of the 
G-quadruplex-forming VNTR sequence and the corresponding 
mode of action of G-quadruplex ligands and ATRX on the G-
quadruplex were studied using reporter assay. Based on these 
results, we propose that G-quadruplex formation and ATRX play 
important roles in regulating the expression of α-globin gene 
cluster. Our results also provide insights into the development of 
drugs for the treatment of α-thalassemia induced by ATRX 
mutations. 
Results and Discussion 
Human α-globin gene expression is regulated by many factors 
including cis-acting and trans-acting elements and this is further 
complicated when the packaging of DNA into chromatin is 
considered. [41] Various upstream regulatory sequences in the α-
globin gene cluster have been identified and it was suggested 
that α-globin gene expression could be controlled by the 
chromatin loops formed by upstream sequences. Recent studies 
indicated that VNTR sequence in the α-globin gene promoter 
region was closely related to gene expression downstream. [39] 
VNTR sequence was located in the promoter region of the HBM 
gene (Figure 1A). This gene was originally found to be a 
pseudogene, but recent studies suggested that it also had a 
protein coding function. [42] 
 
Generally, this VNTR sequence consists of 
CGC(GGGGCGGGG)n repeats despite SNPs (single nucleotide 
polymorphism). The size of VNTR sequence varies among 
individuals and it contains a repeat sequence of approximately 
360 bp in our case (Figure S1). For convenience, ODN 1 
(oligodeoxynucleotide 1) with four CGGGG repeats was used to 
study G-quadruplex formation by the VNTR sequence. As 
shown in Figure 1B, CD spectra of ODN 1 showed that it could 
form a highly stable parallel G-quadruplex in the presence of a 
low concentration of potassium ions (10 mM). UV melting 
experiments also revealed that the parallel G-quadruplex formed 
by ODN 1 had high stability even in the presence of 5 mM K+ 
(Figrue S2). The sequence of ODN 1 closely resembled the G-
quadruplex-forming sequence in the RET promoter reported 
previously. [43] Therefore, it may form similar parallel G-
quadruplex in K+ solutions; the G-quadruplex formed by ODN 1 
is shown in Figure 1C.  
 
Figure 1. G-quadruplex formation in the promoter region of α-globin gene 
cluster. A) The VNTR sequence consists of CGC(GGGGCGGGG)n repeats 
located in the HBM gene promoter. B) CD spectra of ODN 1 (5’-
CGCGGGGCGGGGCGGGGCGGGG-3’) selected from the VNTR sequence. 
ODN 1 formed stable parallel G-quadruplex in the presence of K+. C) 
Representation of the parallel G-quadruplex formed by ODN 1. 
ODN 2, with eight CGGGG repeats, was used to study G-
quadruplex formation by a long repeat sequence. The strong CD 
signals of ODN 2 compared with that of ODN 1 suggested the 
stacking of parallel G-quadruplexes in solutions (Figure 2A). G-
quadruplex formations of ODN 1 and ODN 2 in the presence of 
10 mM K+ were analyzed by native gel electrophoresis. The 
results demonstrated that both ODN 1 and ODN 2 formed 
higher-order G-quadruplex structures in solutions (Figure 2B). 
These results are consistent with previous studies that parallel 
G-quadruplexes formed by DNA and RNA sequences can stack 
together to form higher-order structures [44, 45]. The percentage of 
higher-order structures formed by ODN 2 was high, whereas 
ODN 1 mainly formed a single G-quadruplex. Mutation studies of 
ODN 1 and ODN 2 were also performed as shown in Figure S2. 
Mutations in the G of ODN 1 or in the linker region of ODN 2 
decreased the parallel G-quadruplex formation and higher-order 
structures, suggesting that these repeated sequences are quite 
important to the formation of parallel G-quadruplex and higher-
order G-quadruplexes by VNTR sequence. Therefore, it is likely 
that the long CGC(GGGGCGGGG)n repeat sequence forms 
complex G-quadruplex structures. The i-motif formation by the 
complementary sequence of ODN 1 (ODN 3) was also 
investigated by CD spectroscopy. As shown in Figure 2C, under 
acidic conditions (pH 5.5), ODN 3 showed a positive peak at 
about 288 nm and a negative peak at about 264 nm, indicating 
the formation of the i-motif structure. Together, these results 
suggested that the VNTR sequence with long 
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Figure 2. G-quadruplex and i-motif formation by the long VNTR sequence. A) 
CD spectra of ODN 2 with eight repeats in 100 mM K+ solution. B) G-
quadruplex formation of ODN 1 and ODN 2 analysed by gel electrophoresis. 
C) CD spectra of the i-motif formed by the complementary sequence ODN 3 
(5’-CCCCGCCCCGCCCCGCCCCGCG-3’) at pH 5.5. D) Representation of 
the i-motif formation by the VNTR sequence. 
To investigate G-quadruplex and i-motif formation in the long 
double-stranded DNA, we amplified two double-stranded DNA 
fragments of the HBM promoter from human genome DNA. One 
was approximately 0.9 kb without the VNTR sequence and a 
second was approximately 1.4 kb with the VNTR sequence. The 
G-quadruplex formation in long double-stranded DNA was 
observed with an AFM (Figure 3 and Figure S5). Under acidic 
conditions and in the presence of 100 mM KCl, bunched 
structures was observed in one end of the 1.4 kb DNA 
fragments, suggesting that the duplex DNA changed into single-
stranded structures and formed G-quadruplex as well as i-motif 
structures. In contrast, such structures were not formed in the 
absence of K+ or by the 0.9 kb fragments without VNTR 
sequence (Figure S6). The long VNTR repeat sequence could 
naturally form G-quadruplex and i-motif structures in acidic 
condition with K+ even without annealing or in vitro transcription 
[46, 47]. In our case, the VNTR sequence is quite close to one end 
(Figure S4). The end of duplex could unfold and form G-
quadruplex and i-motif structures with less restrictions. 
Therefore, we could observe branched structures instead of 
bright spots previously reported. [46-48] It suggested the possibility 
of G-quadruplex and i-motif formation during transcription or 
replication when the double-stranded DNA is unfolded into 
single-stranded DNA. Thus, it is possible that such large scale 
G-quadruplex formation will affect gene expressions of HBM and 
other downstream α-globin genes. 
 
It has been comprehensively demonstrated that small molecules 
with G-quadruplex binding affinity can be used to regulate gene 
expressions. [37] TMPyP4 and hemin were used to stabilize G-
quadruplex formation by the VNTR sequence. TMPyP4 has high 
binding affinity towards G-quadruplex and hemin has been 
frequently used for DNAzymes with G-quadruplex. [49-52] UV 
melting experiments were performed to analyze the stabilization 
effect of hemin and TMPyP4 on G-quadruplex formed by ODN 1. 
The ΔTm for hemin was 9 °C and the ΔTm for TMPyP4 was 
higher than 22 °C (Figure S3). Both TMPyP4 and hemin could 
stabilize G-quadruplex formation and the former showed a 
relatively high stabilization effect on parallel G-quadruplex 
formed by the VNTR sequence. 
 
SPR experiments and the DNAzyme experiments were 
performed to further investigate the interaction of G-quadruplex 
with TMPyP4 and hemin. SPR results showed that TMPyP4 had 
a higher binding affinity towards the parallel G-quadruplex 
formed by ODN 1 (KD 6.1×10–7 M) compared with hemin (KD 
2.3×10–5 M) (Figure 4A and Table S1). DNAzyme experiments 
indicated that ODN 1 exhibited a higher catalytic activity similar 
to that of the c-myc sequence (Figure 4B), indicating high 
DNAzyme activity of the parallel G-quadruplex. [53] Interestingly, 
ODN 2 showed relatively low activity. From the gel 
electrophoresis results, it is possible that the high proportion of 
compact, higher-order structures formed by ODN 2 prohibited 
the binding of hemin. [44, 51] 
 
To investigate the effect of G-quadruplex formation on α-globin 
gene expression and the regulatory functions of small molecules 
and ATRX, we performed luciferase reporter assays. Two 
plasmids containing the 1.4 kb (with VNTR sequence) and 0.9 
kb (without VNTR sequence) fragments were constructed and 
transfected into HEK293T cells. We then assessed the gene 
expression by measuring luciferase activities. For hemin and 
TMPyP4, different concentrations of compounds were added 
into medium after transfection. In the case of ATRX, halo-tagged 
ATRX plasmid was cotransfected with constructed plasmids to 
study the effect of ATRX expression on luciferase activities. The 
expression of ATRX in HEK293T cells was confirmed by staining 
with halo tag-specific ligand (Figure S7).  
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Figure 3. AFM images of G-quadruplex and i-motif formation by the long 
VNTR sequence. A) AFM images of samples of the 1.4 kb HBM promoter 
sequence at pH 5.5 in 100 mM KCl solution. B) A topographic zoomed AFM 
image of the DNA containing a branched structure. Positions of branched 
structures are indicated by yellow arrows. 
As shown in Figure 5A, the luciferase activity of the 1.4 kb 
plasmid was lower than that of the 0.9 kb plasmid. This may be 
due to the downregulation effect of the formation of various G-
quadruplex structures by the VNTR sequence. Since the VNTR 
sequence tended to form stable parallel G-quadruplexes and 
even higher-order structures, it might reduce the luciferase 
activity more effectively compared with other G-quadruplex-
forming sequences reported previously. [49] These results hence 
suggested that G-quadruplex formation by the VNTR sequence 
might play an important role in α-globin gene expression, in 
particular in the expression of the HBM gene. 
 
The effect of G-quadruplex ligands were then evaluated (Figure 
5B). Both hemin and TMPyP4 reduced the luciferase activities of 
the 1.4 kb plasmid in a concentration-dependent manner. By 
contrast, the luciferase activities of the 0.9 kb plasmid were 
slightly affected by hemin and TMPyP4. These results showed 
that small molecules that can stabilize parallel G-quadruplex 
formed by the VNTR sequence in the promoter region can 
downregulate gene expressions. The downregulation effect also 
corresponded to the stabilization effect of the G-quadruplex. 
TMPyP4, which had higher stabilization effect on G-quadruplex 
than hemin, showed a more pronounced downregulation effect 
on luciferase gene expression. Moreover, the downregulation 
effect of TMPyP4 in current study was stronger than previous 
results, suggesting the effect of large scale G-quadruplex 
formation by VNTR sequence [47].  
Figure 4. Interaction of TMPyP4 and hemin with the parallel G-quadruplex 
formed by ODN 1. A) SPR sensorgrams of TMPyP4 binding with ODN 1. Two-
site binding model was used to fit the sensorgrams. KD (6.1×10–7 M) was 
calculated by KD1 (2.3×10–7 M) and KD2 (1.6×10–8 M). B) DNAzymes activity of 
different G-quadruplex-forming sequences including c-myc, telomere, ODN 1, 
and ODN 2. 
 
Considering the binding affinity of ATRX to G-quadruplexes, it 
was suggested that ATRX, which has chromatin-remodeling 
activity, might resolve G-quadruplex formation. However, the 
underlying mechanism was not clear as ATRX itself failed to 
unfold the G-quadruplex in vitro. [54] Accordingly, the effect of 
ATRX expression on luciferase activity was analyzed. The 
results showed that ATRX could increase luciferase activity of 
the 1.4 kb plasmid (Figure 5C), suggesting that ATRX might 
reduce the downregulation effect of G-quadruplex formation by 
the VNTR sequence. These results supported the hypothesis 
that ATRX could resolve the potential G-quadruplex formation in 
GC-rich regions. The results of luciferase reporter assays shown 
above indicated that G-quadruplex formation by the VNTR 
sequence in the HBM promoter might have important regulatory 
functions on α-globin gene expressions. More importantly, ATRX 
that could bind to GC-rich regions might be involved in and help 
facilitate gene expression downstream.  
 
Human hereditary disorders that are caused by one simple 
repeat expansion suggested the negative impact of the non-B-
form DNA structures formed by repeat sequences. [21] For a 
particular gene, such repeat sequences located in coding or 
noncoding regions would strongly disrupt normal gene 
expression and even generate toxic repeat RNA transcripts. [25, 26] 
As to ATR-X syndrome, α-thalassemia, which is the 
downregulation of α-globin expression, is related to the VNTR 
sequences found in the promoter region of the HBM gene. In the 
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current study, we established that stable G-quadruplex and i-
motif structures could be formed by this repeat sequence and 
showed that more complex structural features were formed in 
the long double-stranded DNA. The results of luciferase 
experiments revealed a clear downregulation effect of the VNTR 
sequence on luciferase activity. In a simple model, the formation 
of non-B-form DNA structures would generate structural 
disturbances in the B-form DNA on a large scale, which could 
disrupt the binding of transcription factors and ultimately hamper 
the transcription. Given the complex regulation network in the α-
globin cluster, the formation of non-B-form DNA structures would 
affect the gene expression of other α-globin genes downstream. 
VNTR sequence could also form G-quadruplex structures during 
DNA replication. These structures could stall replication forks 
and cause genomic and epigenetic instability. For example, 
reduced α-globin expression could be caused by the loss of 
activating histone marks at the α-globin gene during 
replication.[55, 56] Therefore, the size of the VNTR sequence is 
related to the downregulation effect of gene expression 
downstream, which is consistent with previous reports. [39] 
 
Figure 5. Luciferase reporter assays of the 1.4 kb and 0.9 kb HBM promoter 
regions. A) Luciferase activity of 1.4 kb promoter sequence and 0.9 kb 
promoter sequence. Luciferase activity of the 1.4 kb HBM promoter sequence 
was almost two fold higher than that of the 0.9 kb HBM promoter sequence. B) 
Effect of hemin and TMPyP4 on the luciferase activity. In the presence of G-
quadruplex ligands hemin and TMPyP4, luciferase activity of the 1.4 kb HBM 
promoter sequence decreased in a concentration-dependent manner, whereas 
luciferase activity of the 0.9 kb HBM promoter sequence was slightly reduced. 
C) Effect of ATRX expression on the luciferase activity. ATRX expression by 
transfection of ATRX plasmids recovered the luciferase activity of the 1.4 kb 
HBM promoter sequence. The data are mean ± SD of repeated experiments 
(n = 3). 
 
Considering the large effect of the non-B-form DNA structures 
formed by repeat sequences, the resolution of these structures 
is important for the maintenance of gene expression in normal 
cells. Various helicases that can unfold G-quadruplex structures 
in the presence of ATP have been reported. [57, 58] Proteins that 
could resolve G-quadruplex structures by shifting the duplex–
quadruplex equilibrium have also been identified. [33, 57] ATRX is 
thought to resolve G-quadruplex based on its location on a GC-
rich region and its chromatin-remodeling function. The results of 
our reporter assay also suggested that ATRX expression could 
regenerate the downregulation effect caused by the VNTR 
sequence. Although ATRX has the helicase domain, previous 
results have shown that it can bind to G-quadruplex, but cannot 
unfold the G-quadruplex in the presence of ATP like BLM 
helicase. [54] These results suggested that ATRX may resolve G-
quadruplex formation by other mechanisms. Recent reports 
have shown that the helicase domain of ATRX could also bind to 
duplex DNA. [17] Therefore, ATRX may resolve G-quadruplex 
structures by changing the duplex–quadruplex equilibrium. It has 
also been shown by NMR spectroscopic and crystallographic 
analyses that the ADD domain of ATRX can specifically 
recognize a histone tag with H3K9me3. [8, 9] ATRX and DAXX 
together can facilitate the incorporation of histone H3.3 variant. [1] 
Considering these functions of ATRX, it is possible that the 
resolution of G-quadruplex by ATRX is related to its chromatin-
remodeling activity. Overall, ATRX may unfold the G-quadruplex 
structure or change the duplex–quadruplex equilibrium at a 
nucleosome level. 
 
For the α-thalassemia in ATR-X patients, mutations are usually 
found in either the ADD domain or the helicase domain. These 
mutations would disrupt the chromatin-remodeling activity or G-
quadruplex resolution function, can promote the G-quadruplex 
formation by the VNTR sequence, which in turn results in the 
downregulation of α-globin gene expressions. The size of the 
VNTR sequences in patients is also important because it may 
affect the stability or scale of G-quadruplex formation. Therefore, 
we propose that ATRX mutations and the VNTR sequences are 
both involved in the pathogenesis of α-thalassemia in ATR-X 
patients, and like other repeat expansions, the VNTR sequence 
tends to form non-B-form DNA during replication and 
transcription. Possible higher-order G-quadruplex structure may 
also be involved. Normally, ATRX will locate to this region, 
resolve G-quadruplex formation and incorporate histone 3.3 with 
DAXX. However, mutations in ATRX will disrupt either the 
location of ATRX or the resolution of the G-quadruplex by ATRX. 
Therefore, the G-quadruplex formed by the VNTR sequence will 
remain, leading to reduced levels of α-globin gene expression 
and finally causing α-thalassemia. 
Conclusions 
In summary, we have investigated G-quadruplex and i-motif 
formation by the VNTR sequence in the promoter region of α-
globin gene cluster. Our findings showed that stable G-
quadruplex structures could be formed by single-stranded DNA 
and higher-order G-quadruplex structures could be formed by 
long double-stranded DNA containing the VNTR sequence. The 
effect of G-quadruplex formation and ATRX expression were 
evaluated by conducting luciferase assays. The G-quadruplex 
formation by the VNTR sequence could downregulate luciferase 
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activity, whereas ATRX could reverse this downregulation effect. 
Our results suggested the regulatory functions of ATRX and G-
quadruplex formation by VNTR in the α-globin gene expressions. 
A model of ATRX and G-quadruplex formation was proposed 
and it might explain the vital disease-causing role of different 
size of VNTR sequence and ATRX mutations found in ATR-X 
patients. These results help to explain the mechanism of α-
thalassemia in ATR-X syndrome and provide insights into the 
treatment for this debilitating condition. 
Experimental Section 
CD spectra: All oligonucleotides were purchased from Sigma-Aldrich Co. 
LLC. (Japan) without further purification. Oligonucleotides for CD spectra 
were prepared in Li+ solution (20 mM lithium cacodylate, pH 7.0, 100 mM 
LiCl), Na+ solution (20 mM lithium cacodylate, pH 7.0, 100mM NaCl) or 
K+ solution (20 mM lithium cacodylate, pH 7.0, 100 mM KCl). Annealing 
was performed by heating to 95°C for 5 min and cooling down to room 
temperature slowly. CD spectra were measured in 0.5-nm steps from 340 
to 220 nm using JASCO J-805LST Spectrometer in a 1-cm quartz 
cuvette. 
UV melting experiment: UV–Vis melting temperature analyses were 
performed on a spectophotometer V-650 (JASCO, Japan) with a 
thermocontrolled PAC-743R cell changer (JASCO, Japan) and a 
refrigerated and heating circulator F25-ED (Julabo). Hemin (51280) and 
TMPyP4 (323497) were purchased from Sigma-Aldrich Co. LLC. (Japan). 
Oligonucleotides (5 µM) in K+ solution (20 mM lithium cacodylate, pH 7.0, 
5 mM KCl) and 1 eq compounds were added. Annealing was performed 
by heating to 95°C for 5 min and cooling down to room temperature 
slowly. Melting temperature(Tm of each samples were measured at 295 
nm from 20 to 90°C at a rate of 1.0 °C /min. ΔTm were calculated by the 
Tm values of samples with and without compounds.  
Gel electrophoresis: For the single-stranded oligonucleotides, DNA 
samples for gel electrophoresis were prepared similarly with the samples 
of CD spectra while the KCl concentration was 10 mM. Oligonucleotides 
were prepared in K+ solution (20 mM lithium cacodylate, pH 7.0, 10 mM 
KCl). Annealing was performed by heating to 95°C for 5 min and cooling 
down to room temperature slowly. Each sample was analysed by native 
gel (16%) in 1×TBE buffer containing 10 mM KCl at room temperature. 
The single-stranded DNA was stained with SYBR® Gold nucleic acid gel 
stain (S-11494, Thermo Fisher Scientific Inc. Japan). 20 bp DNA Ladder 
(3420A, Takara, Japan) was used as marker. The gels were then imaged 
by FLA-3000 (FUJIFILM, Japan).  
AFM imaging: The 1.4 kb and 0.9 kb HBM promoter sequences were 
amplified from human genomic DNA using AccuPrime™ GC-Rich DNA 
Polymerase (Life Technologies, Japan). The DNA fragments were diluted 
to a concentration of 0.5 ng/µl in a buffer containing 20 mM MES-NaOH 
(pH 5.5) and 100 mM KCl. After incubation at room temperature for 1 
hour, 2 µl of the samples were deposited onto freshly cleaved mica discs 
pretreated with 0.1% 3-aminopropyletrithoxy silane (APTES). After 3 min 
incubation, the sample was rinsed with 10 µl washes of the buffer, and 
imaged in the same buffer. AFM imaging was performed using a high-
speed AFM system (Nano Live Vision, RIBM, Tsukuba, Japan) and small 
cantilevers with the dimensions (L × W × H) of 10 × 2 × 0.1 µm3 (BL-
AC10EGS, Olympus Corporation).  
Surface plasmon resonance (SPR) assay: SPR experiments were 
performed using a BIACORE X instrument. The biotinylated ODN 1 (5’-
bitoin-TTTTCGCGGGGCGGGGCGGGGCGGGG-3’) were immobilized 
on a streptavidin-coated sensor chip SA to obtain the desired 
immobilization levels. Experiments were performed using degassed and 
filtered HBS (10 mM HEPES, 150 mM NaCl, 3 mM EDTA, and 0.005% 
surfactant P20) buffer with 100 mM KCl at 25 °C (pH 7.4). Sample 
solutions at various concentrations were prepared in HBS-EP buffer with 
100 mM KCl and injected at a flow rate of 20 µL/min. Data processing 
was performed by global fitting of the sensorgrams obtained 
experimentally to a model of two site binding using the BIAevaluation 4.1 
software. 
DNAzyme experiments: Generally, DNAzyme solution with 1µM DNA in 
K+ solution (20 mM lithium cacodylate, pH 7.0, 100 mM KCl) was 
prepared and annealing was performed by heating to 95°C for 5 min and 
cooling down to room temperature slowly. Then hemin and 2, 2’-azino-di-
[3-ethylbenzthiazoline sulfonate (ABTS) were added to the final 
concentration of 1 µM and 2 mM accordingly. DNAzyme experiments 
were started by adding 10 µL H2O2 (final concentration 1 mM). 
Absorption of the solution at 420 nm was collected every 30 seconds 
from 0 to 60 min a spectophotometer V-650 (JASCO, Japan) in a time-
dependent method. 
Luciferase reporter assay: The HBM promoter sequences were 
amplified from human genomic DNA using AccuPrime™ GC-Rich DNA 
Polymerase (Life Technologies, Japan). The pMCS Cypridina luciferase 
reporter (Thermo Scientific, Japan) plasmids containing HBM promoter 
were constructed. HEK293T cells (ATCC, Japan) were seeded in 24-well 
plates with 8×104 cells/well. To observe the effect of the G-quadruplex 
ligands, the plasmid containing the HBM promoter (1 µg) was transfected 
into the cells using FuGENE 6 transfection reagent (Promega, Japan). 
After 2 hr the cells were treated with 1 µM and 10 µM compounds. To 
understand the role of ATRX, halo-tag ATRX plasmid (Kazusa DNA 
Research Institute, Japan) and the HBM promoter plasmids were 
cotransfected by Lipofectamine® 3000 Transfection Reagent (Life 
Technologies, Japan). The luciferase activity was measured after 48 hr 
with Pierce Cypridina luciferase Flash Assay Kit (Thermo Scientific, 
Japan) at 463 nm using a Spectra Max 190 (Molecular Devices, Japan) 
microplate reader. 
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Oligonucleotides and primers used in this study 
 
ODN 1 5’-CGCGGGGCGGGGCGGGGCGGGG-3’ (22mer) 
ODN 2 5’-CGCGGGGCGGGGCGGGGCGGGGCGGGGCGGGGCGGGGCGGGG-3’ (42mer) 
ODN 3 5’-CCCCGCCCCGCCCCGCCCCGCG-3’ (22mer) 
ODN 4 5’-CGCGGTGCGGGGCGGGGCGGGG-3’ (22mer) 
ODN 5 5’-CGCGGGGCGTGGCGGGGCGGGG-3’ (22mer) 
ODN 6 5’-CGCGGGGCGGGGCGGTGCGGGG-3’ (22mer) 
ODN 7 5’-CGCGGGGCGGGGCGGGGCGTGG-3’ (22mer) 
ODN 8 5’-CGCGGGGCGGGGCGGGGCGGGGCTTTTCGGGGCGGGGCGGGG-3’ (42mer) 
ODN 9 5’-CGCGGGGCGGGGCGGGGCGGGGCTTTTGGGGCGGGGCGGGGCGGGG-3’ (46mer) 
Biotin-ODN 1 5’-bitoin-TTTTCGCGGGGCGGGGCGGGGCGGGG-3’ 
c-myc 5’-GGGGAGGGTGGGGAGGGTGGGGAAGG-3’ 
telomere 5’-AGGGTTAGGGTTAGGGTTAGGG-3’ 
Forward primer for 1.4 kb 5’-TACATCCTGCGCGTGGACCCGGT-3’ 
Forward primer for 0.9 kb 5’-CTGTCCCACTGCCTGCTGGTCA-3’ 



































Figure S1. VNTR sequence was located in the promoter region of HBM gene in the α-globin gene cluster. It contains hundreds 
of CGC(GGGGCGGGG)n repeats and the size of VNTR sequence is variable among individuals. Here is an example of whole 






























Figure S2. Mutation studies of G-quadruplex formation by VNTR sequence. CD spectra (A and B) and gel analysis (C) of ODN 















Figure S3. UV melting temperature of ODN 1 (A), ODN 1 with hemin (B) and ODN 1 with TMPyP4 (C). Oligonucleotides (5 µM) 
in K+ solution (20 mM lithium cacodylate, pH 7.0, 5 mM KCl) and 1 eq compounds were added. The melting temperature of 
ODN 1 with TMPyP4 was higher than 90 °C in 5 mM KCl, indicating the high stabilization ability of TMPyP4 towards G-















































Figure S5. AFM images of the 1.4 kb HBM promoter sequence were obtained at pH 5.5 in 100 mM KCl solution. Three types of 
structures were identified: B (branched structure), N (non-branched structure) and U (unidentified structure). The percentage of 










Figure S6. A) AFM images of 1.4 kb sequence in pH 5.5 without K+. B) AFM images of 1.4 kb sequence in pH 7.6 with 100 mM 
K+. C) AFM images of 0.9 kb sequence without VNTR G-quadruplex-forming sequence. In all three cases, no branched 

























 Compounds KD1 KD2 KD ΔTm 
Hemin 8.5×10–5 M 6.2×10–6 M 2.3×10–5 M 9 °C 
TMPyP4 2.3×10–7 M 1.6×10–8 M 6.1×10–7 M >22 °C 
 
Table S1. Binding affinity of hemin and TMPyP4 towards G-quadruplex formed by ODN 1. Two-site binding model (black line) 
was used to compare with TMPyP4. KD (2.3×10–5 M) was calculated by KD1 (8.5×10–5 M) and KD2 (6.2×10–6 M) based on two-
site binding model. Compared with TMPyP4 (KD 6.1×10–7 M), hemin has a larger KD (2.3×10–5 M), which is consistent with the 










































Figure S7. Expression of ATRX in the HEK293T cells. A) Staining of HEK293T cells with DAPI. B) Staining of HEK293T cells 
with HaloTag® TMR Ligand. C) Merge of DAPI and HaloTag® TMR Ligand staining. Halo-tag ATRX plasmid (Kazusa DNA 
Research Institute, Japan) was transfected into HEK293T cells by Lipofectamine® 3000 Transfection Reagent (Life 
Technologies). After 2 days, cells were stained with DAPI and HaloTag® TMR Ligand (G8251, Promega) following the product 
instructions. Then cell images were obtained by FV1200 Laser Scanning Microscopes (Olympus, Japan). 
 
